Description

Liver Hydrolyzed Peptide Injection is produced from healthy porcine and bovine liver via enzymatic hydrolysis. The resulting sterile solution contains peptides, amino acids, and nucleotides. It is widely used experimentally to stimulate protein synthesis, hepatocyte regeneration, and reduce oxidative damage in liver disease models including chronic hepatitis and liver fibrosis

Manufactured by Jilin Aodong Pharmaceutical Group Yigantai Co., Ltd., this injectable supports research into hepatic function recovery, protein synthesis promotion, and antioxidant activity in liver injury models.

Product Specifications

Mechanism of Action

Liver hydrolyzed peptides:

• Stimulate protein synthesis and suppress degradation in hepatocytes

• Promote liver cell proliferation and regeneration after CCl?-induced damage

• Enhance antioxidant enzyme activity to counter oxidative stress in liver tissue

Research Applications

• Chronic hepatitis and liver fibrosis models

• Hepatoprotective studies post CCl? or toxin challenge

• Hepatocyte regeneration and protein turnover assays

• Oxidative stress and ROS suppression in liver disease models

• Hematopoietic and liver-supportive research in bone marrow suppression models

Safety & Handling

• For research use only: not for human or veterinary administration.

• Use proper lab PPE (gloves, lab coat, goggles).

• Store sealed and avoid exposure to high temperatures (heat may cloud solution) .

• Discard if appearance changes or precipitates form.

Core Keywords

liver hydrolyzed peptide injection, heparolysate injection, Aodong Yigantai liver peptides, hepatocyte regeneration injection, NMPA H22024567, research liver model compound, antioxidant liver peptide, chronic hepatitis research drug

Research Use Disclaimer

This product is strictly for laboratory and experimental research only. It is not approved for clinical, diagnostic, therapeutic, or veterinary use. Improper use may pose health or legal risks. Use under institutional protocols.